| Age, years, mean±SD |
66.7±10.2 |
65.6±10.0 |
| Female gender, n (%) |
24 (24.7) |
21 (21.4) |
| Body mass index, mean±SD |
28.1±4.1 |
28.3±4.1 |
| Coronary risk factors |
Diabetes mellitus, n (%) |
30 (30.9) |
32 (32.7) |
| Past or current smoker, n (%) |
58 (61.7) |
61 (64.9) |
| Hypercholesterolaemia, n (%) |
65 (67) |
69 (70.4) |
| Hypertension, n (%) |
59 (60.8) |
69 (70.4) |
| Comorbidities |
Renal insufficiency, n (%) |
4 (4.1) |
6 (6.1) |
| Liver disease, n (%) |
3 (3.1) |
1 (1) |
| Chronic lung disease, n (%) |
9 (9.3) |
16 (16.3) |
| Previous stroke, n (%) |
5 (5.2) |
11 (11.2) |
| History of malignancy, n (%) |
8 (8.2) |
5 (5.1) |
| Congestive heart failure, n (%) |
5 (5.2) |
6 (6.1) |
| Previous MI, n (%) |
20 (20.6) |
22 (22.7) |
| Previous PCI, n (%) |
26 (26.8) |
32 (32.7) |
| Previous CABG, n (%) |
2 (2.1) |
6 (6.1) |
| Indication for PCI |
Chronic coronary syndrome, n (%) |
45 (46%) |
50 (51%) |
| Unstable angina, n (%) |
13 (13.4) |
7 (7.1) |
| Non-STEMI, n (%) |
21 (21.6) |
25 (25.5) |
| STEMI, n (%) |
18 (18.6) |
16 (16.3) |
| No significant differences were observed between groups except for bifurcation lesions (p=0.019). BF-CoCr: BioFreedom cobalt-chromium stent; BF-SS: BioFreedom stainless steel stent; CABG: coronary artery bypass graft; MI: myocardial infarction; PCI: percutaneous coronary intervention; STEMI: ST-segment elevation myocardial infarction |
